Herston, Australia

Rajiv Khanna

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Hentson, AU (1999)
  • Herston, AU (2004 - 2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovator Rajiv Khanna: Pioneering Advances in Immunotherapy

Introduction

Rajiv Khanna, based in Herston, Australia, is a prominent inventor known for his significant contributions to the field of immunotherapy. With a successful portfolio of ten patents, Khanna’s work focuses on developing innovative methods to enhance the immune response against human herpesviruses, positioning him as a leader in medical research.

Latest Patents

Khanna's latest patents include groundbreaking work on human herpesvirus immunotherapy. One notable patent describes an isolated protein that comprises amino acid sequences from various cytotoxic T lymphocyte (CTL) epitopes across multiple herpesvirus antigens. This isolated protein is specifically engineered to expand human CTLs in vitro and trigger an immune response in vivo when administered to an animal. The protein typically consists of no more than twenty CTL epitopes derived from cytomegalovirus and/or Epstein-Barr virus antigens. Furthermore, Khanna has developed methods and compositions for selecting T cells and subjects for adoptive immunotherapy, enhancing the efficacy of treatment based on specific biomarkers.

Career Highlights

Rajiv Khanna has a noteworthy career marked by his involvement with significant institutions, notably the Queensland Institute of Medical Research. His research efforts have been instrumental in advancing our understanding of viral immunology and developing practical therapeutic applications aimed at improving patient outcomes in viral infections.

Collaborations

Throughout his career, Khanna has collaborated with esteemed colleagues, including Scott Renton Burrows and Beverley Mavis Kerr. These collaborations have fostered a robust research environment that encourages innovative solutions to complex medical challenges.

Conclusion

Rajiv Khanna is a distinguished inventor whose contributions to immunotherapy exemplify the remarkable potential of scientific innovation in combating viral diseases. His ten patents reflect a commitment to enhancing human health through targeted research and collaboration, establishing him as a vital figure in contemporary medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…